FDA approves angiotensin II for distributive shock

The FDA approved angiotensin-II (Giapreza) as a new intravenous vasopressor for septic shock and other forms of distributive shock. The first new FDA-approved vasopressor in decades.
This is based on recent trial, which was discussed here.


Chest compressions should start when systolic arterial blood pressure is below 50 mm Hg in the anaesthetised patient.Read more
%d bloggers like this: